Home / Import refusals / 231-1162416-2/171/1

FDA Import Refusal 231-1162416-2/171/1 — Catalent Pharma Solutions, LLC

Catalent Pharma Solutions, LLC — FEI 1811396

The FDA refused shipment 231-1162416-2/171/1 from Catalent Pharma Solutions, LLC (United States) on January 6, 2017. The refused product falls under Drugs and Biologics — ANTI-CHOLESTEREMIC, N.E.C.. Cited charge: 118 This firm has 5 or more other import refusals on record.

Refusal Details

Date
January 6, 2017
Country
United States
Product Category
Drugs and Biologics
Product Code
61JCH99 ANTI-CHOLESTEREMIC, N.E.C.
Charges
118

Recent inspections

  • 1282788 (VAI Fri Jan 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229815 (NAI Thu May 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229344 (NAI Thu Jan 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1210540 (VAI Fri Jul 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1101180 (VAI Wed Aug 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • CWL-1149924-2/11/1 (Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 231-1167502-4/211/1 (Wed Jul 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 231-1159559-4/9/1 (Fri Oct 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 231-1159559-4/10/1 (Fri Oct 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 231-1157469-8/1/2 (Mon Aug 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources